Form 4: United States Antimony Director Joseph Carrabba Reports Significant Equity Grants and Vesting

Sentiment:

Insider Transaction Report


United States Antimony Corp. Director Joseph A. Carrabba reported the grant and partial vesting of restricted stock units and stock options on May 27, 2025, under the company's 2023 Equity Incentive Plan.

Summary

  • Director Joseph A. Carrabba of United States Antimony Corp. (UAMY) reported transactions on May 27, 2025, related to equity compensation.
  • He acquired 22,733 shares of Common Stock at a price of $0, which represent the initial vesting portion of a time-based Restricted Stock Unit (RSU) award.
  • This RSU award is part of a larger grant totaling 68,200 shares under the Issuer's 2023 Equity Incentive Plan.
  • One-third (22,733 shares) of the RSU award vested on May 27, 2025, with the remaining two-thirds scheduled to vest on May 27, 2026, and May 27, 2027, contingent on his continued service.
  • Following this transaction, Mr. Carrabba directly beneficially owns 106,067 shares of Common Stock.
  • Additionally, he was granted 34,100 stock options with an exercise price of $2.57, also under the 2023 Equity Incentive Plan.
  • These stock options will vest in three equal annual installments, with one-third (11,367 shares) vesting on May 27, 2026, and subsequent one-third portions vesting on May 27, 2027, and May 27, 2028, subject to his continued service.

Sentiment

Score: 7

Explanation: The document reports standard equity compensation for a director, which is generally a positive sign of aligning interests and retaining talent. It doesn't contain negative news or significant positive operational updates, hence a neutral-to-slightly positive score.

Positives

  • The grant of restricted stock units and stock options aligns the director's interests with long-term shareholder value.
  • The multi-year vesting schedule encourages continued service and commitment from a key director.
  • The awards are made under the company's 2023 Equity Incentive Plan, indicating a structured and approved approach to executive compensation.

Negatives

  • The Form 4 itself, as a disclosure of compensation, does not inherently present negative information.

Risks

  • Future vesting of the remaining RSUs and stock options is contingent upon the reporting person's continued service to the company.
  • The ultimate value realized from the stock options is dependent on the future market price of UAMY common stock exceeding the exercise price of $2.57.

Future Outlook

The future outlook indicates that additional tranches of the RSU award and stock options will vest annually on May 27, 2026, May 27, 2027, and for stock options, also on May 27, 2028, contingent upon the director's continued service to the company.

Industry Context

This Form 4 filing reflects standard executive compensation practices within publicly traded companies, where equity awards like Restricted Stock Units (RSUs) and stock options are commonly used to incentivize and retain directors and executives, aligning their long-term interests with shareholder value. Such awards are typical across various industries, including the mining and materials sector where United States Antimony Corp. operates.

Comparison to Industry Standards

  • The use of time-based vesting Restricted Stock Units (RSUs) and stock options with multi-year vesting schedules is a common practice in executive compensation across industries, including the mining and materials sector.
  • For instance, companies like Coeur Mining (CDE) or Hecla Mining (HL) often utilize similar equity incentive plans to compensate their directors and executives, tying a portion of their remuneration to the company's long-term performance and continued service.
  • The specific exercise price of $2.57 for the options would typically be evaluated against UAMY's stock price performance and peer group option grants at the time of issuance to assess its competitiveness and incentive value, though this document does not provide enough information for a direct comparison of specific values against peers.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive Plan UtilizationThe grant of RSUs and stock options was made under the Issuer's 2023 Equity Incentive Plan, indicating the ongoing use of this plan for executive and director compensation.05/27/2025Reinforces the company's established framework for aligning director incentives with shareholder interests through equity-based compensation.

Stakeholder Impact

  • Shareholders: The equity grants align the director's long-term interests with shareholder value, potentially leading to more focused decision-making aimed at stock price appreciation.
  • Employees: While this specific filing is about a director, the existence of an equity incentive plan suggests a broader framework for employee incentives, which can positively impact morale and retention.

Next Steps

  • Future vesting of 22,734 RSU shares on May 27, 2026, subject to continued service.
  • Future vesting of 22,733 RSU shares on May 27, 2027, subject to continued service.
  • Future vesting of 11,367 stock option shares on May 27, 2026, subject to continued service.
  • Future vesting of 11,367 stock option shares on May 27, 2027, subject to continued service.
  • Future vesting of 11,366 stock option shares on May 27, 2028, subject to continued service.

Key Dates

DateDescription
05/27/2025Date of grant and initial vesting of Restricted Stock Units (RSUs) and grant of Stock Options.
05/27/2026Date for the second one-third vesting of RSUs and first one-third vesting of Stock Options.
05/27/2027Date for the final one-third vesting of RSUs and second one-third vesting of Stock Options.
05/27/2028Date for the final one-third vesting of Stock Options.
06/10/2025Date the Form 4 was signed by Joseph Carrabba.

Recommendation

hold

Keywords

SEC Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, Stock Options, Equity Incentive Plan, Director Compensation, UAMY, United States Antimony Corp, Joseph Carrabba

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.